Efficacy of LY333328 against Experimental Methicillin-Resistant Staphylococcus aureus Endocarditis

The in vivo efficacy of LY333328, a new glycopeptide antibiotic, was compared with that of vancomycin by using the rabbit model of left-sided methicillin-resistant Staphylococcus aureus endocarditis. Animals received LY333328 or vancomycin (25 mg/kg of body weight every 24 or 8 h, respectively) for...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kaatz, Glenn W., Seo, Susan M., Aeschlimann, Jeffrey R., Houlihan, Heather H., Mercier, Renee-Claude, Rybak, Michael J.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 1998
Matèries:
Experimental Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC105587/
https://ncbi.nlm.nih.gov/pubmed/9559828
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars